Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity: letter to the editor

Caroline Benedicte Kjærulff Mathiesen

doi:10.1016/j.jaci.2018.07.030

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity: letter to the editor

Caroline Benedicte Kjærulff Mathiesen

Københavns Universitet

Publikation: Bidrag til tidsskrift › Tidsskriftsartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Journal of Allergy and Clinical Immunology
Vol/bind	142
Udgave nummer	6
Sider (fra-til)	1983-1987
Antal sider	5
ISSN	0091-6749
DOI	https://doi.org/10.1016/j.jaci.2018.07.030
Status	Udgivet - dec. 2018
Udgivet eksternt	Ja

Adgang til dokumentet

10.1016/j.jaci.2018.07.030

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{54486a910ad042caa94be505880948b7,

title = "Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity: letter to the editor",

author = "Mathiesen, \{Caroline Benedicte Kj{\ae}rulff\}",

note = "Funding Information: Supported in part by the Danish Research Councils ( 1331-00133B ); a program of excellence 2016 (CDO2016: 2016CDO04210) from the University of Copenhagen; the Danish National Research Foundation (DNRF107); the Carl Emil Friis og hustru Olga Doris Friis Foundation; the Lundbeck Foundation; the A.P. M{\o}ller og Hustru Chastine Mc-Kinney M{\o}llers Fond til Almene Formaal, Kirsten og Freddy Johansen Fonden, Mizutani Foundation; and the Novo Nordisk Foundation.",

year = "2018",

month = dec,

doi = "10.1016/j.jaci.2018.07.030",

language = "English",

volume = "142",

pages = "1983--1987",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "6",

}

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity: letter to the editor. / Mathiesen, Caroline Benedicte Kjærulff.
I: Journal of Allergy and Clinical Immunology, Bind 142, Nr. 6, 12.2018, s. 1983-1987.

Publikation: Bidrag til tidsskrift › Tidsskriftsartikel › Forskning › peer review

TY - JOUR

T1 - Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

T2 - letter to the editor

AU - Mathiesen, Caroline Benedicte Kjærulff

N1 - Funding Information: Supported in part by the Danish Research Councils ( 1331-00133B ); a program of excellence 2016 (CDO2016: 2016CDO04210) from the University of Copenhagen; the Danish National Research Foundation (DNRF107); the Carl Emil Friis og hustru Olga Doris Friis Foundation; the Lundbeck Foundation; the A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til Almene Formaal, Kirsten og Freddy Johansen Fonden, Mizutani Foundation; and the Novo Nordisk Foundation.

PY - 2018/12

Y1 - 2018/12

UR - https://www.scopus.com/pages/publications/85053832575

U2 - 10.1016/j.jaci.2018.07.030

DO - 10.1016/j.jaci.2018.07.030

M3 - Journal article

SN - 0091-6749

VL - 142

SP - 1983

EP - 1987

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 6

ER -